EverImmune
EverImmune is a microbial Immunotherapy founded in 2016.
5
Funding Rounds
$5.7m
Money raised
Overview
EverImmune is a microbial Immunotherapy founded in 2016.
- Websites:
- Business model: B2B
- Headquarters: Paris
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company EverImmune has raised a total of $25.7m in funding over 5 rounds.
Key Insights:
- EverImmune September 2023 Debt Funding Round: $3.7m
- EverImmune November 2021 Series A Funding Round: $5.3m
- EverImmune November 2021 Series A Funding Round: $5.3m
- EverImmune Series A round, November 2021: $5.7m
- EverImmune November 2021 Series A Funding Round: $5.7m
EverImmune September 2023 Debt Funding Round
$3.7m
EverImmune November 2021 Series A Funding Round
$5.3m
EverImmune November 2021 Series A Funding Round
$5.3m
EverImmune Series A round, November 2021
$5.7m
EverImmune November 2021 Series A Funding Round
$5.7m
Industries
EverImmune is active in the following industries: